Post by Simon-Kucher

Three years of MFN agreements. What happens next? Subpoena risk and congressional codification that looks nothing like the US administration's framework. GLOBE and GUARD may have been leverage all along. Have they already served their purpose? We map the Most Favored Nation drug pricing scenarios pharma executives need to be stress-testing now. Read our latest MFN analysis here: skp.link/ybro #BetterMarketAccess #MFN #Pharma #MarketAccess #PricingStrategy